In just the first quarter of 2019, Nationwide Children’s Hospital is on track to bring in more than $25 million in revenue from licensing income from technology developed in its labs.
That includes more than $18 million from the recent sale of a gene therapy spinout. The total from that deal still is being calculated, but more than $7.5 million revenue from a diverse portfolio before that deal has the hospital on track for steady income that doesn’t rely on one-time bonanzas.
Click here to read the complete article.
Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.
Originally published March 5, 2019.